Genomic and molecular aberrations in malignant peripheral nerve sheath tumor and their roles in personalized target therapy

Surgical Oncology

Volumn 22, Issue 3, 2013, Pages

  Yang, Jilong ^a   Du, Xiaoling ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Genetic aberration; Malignant peripheral nerve sheath tumor; Microarray based comparative genomic hybridization; Personalized medicine; Target therapy

Indexed keywords

BINDING PROTEIN; BIRC5 PROTEIN; COLLAGENASE 3; CYCLIN DEPENDENT KINASE 6; DNA TOPOISOMERASE (ATP HYDROLYSING) A; E1A ENHANCER BINDING PROTEIN; EARLY GROWTH RESPONSE FACTOR 1; EPIDERMAL GROWTH FACTOR RECEPTOR; GLUTATHIONE TRANSFERASE T1; LYSYL OXIDASE LIKE 2 PROTEIN; MATRIX METALLOPROTEINASE 15; PEPTIDES AND PROTEINS; PROTEIN BCL 3; PROTEIN KINASE B BETA; PROTEIN LYSINE 6 OXIDASE; PROTEIN MSH2; PROTEIN P53; SCATTER FACTOR RECEPTOR; SOMATOMEDIN C; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG; UVOMORULIN; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

ACOUSTIC NEURINOMA; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CARCINOGENESIS; CHROMOSOME 16P; CHROMOSOME 17Q; CHROMOSOME 19; CHROMOSOME 1Q; CHROMOSOME 22; CHROMOSOME 22Q; CHROMOSOME 4Q; CHROMOSOME 7; CHROMOSOME ABERRATION; CHROMOSOME BAND; CHROMOSOME NUMBER; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE FREE SURVIVAL; GENE DELETION; GENE DOSAGE; GENOMIC INSTABILITY; HUMAN; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; MALIGNANT TRANSFORMATION; MICROARRAY ANALYSIS; NEURILEMOMA; NEUROFIBROMA; PATHOGENESIS; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE; REVIEW; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

GENETIC ABERRATION; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; MICROARRAY-BASED COMPARATIVE GENOMIC HYBRIDIZATION; PERSONALIZED MEDICINE; TARGET THERAPY;

GENE EXPRESSION PROFILING; GENOMICS; HUMANS; INDIVIDUALIZED MEDICINE; MOLECULAR TARGETED THERAPY; NERVE SHEATH NEOPLASMS; PROGNOSIS; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84883824488     PISSN: 09607404     EISSN: 18793320     Source Type: Journal    
DOI: 10.1016/j.suronc.2013.06.003     Document Type: Review

References (34)

1. G. Gupta, and A. Maniker Malignant peripheral nerve sheath tumors Neurosurg Focus 22 2007 E12
2. B. Fuchs, R.J. Spinner, and M.G. Rock Malignant peripheral nerve sheath tumors: an update J Surg Orthop Adv 14 2005 168 174
3. P. Levy, D. Vidaud, K. Leroy, I. Laurendeau, J. Wechsler, and G. Bolasco Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR Mol Cancer 3 2004 20
4. J. Yu, H. Deshmukh, J.E. Payton, C. Dunham, B.W. Scheithauer, and T. Tihan Array-based comparative genomic hybridization identifies CDK4 and FOXM1 alterations as independent predictors of survival in malignant peripheral nerve sheath tumor Clin Cancer Res 17 2011 1924 1934
5. S. Ugras, E. Brill, A. Jacobsen, M. Hafner, N.D. Socci, and P.L. Decarolis Small RNA sequencing and functional characterization reveals MicroRNA-143 tumor suppressor activity in liposarcoma Cancer Res 71 2011 5659 5669
6. M. Sultan, M.H. Schulz, H. Richard, A. Magen, A. Klingenhoff, and M. Scherf A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome Science 321 2008 956 960
7. D.M. Thomas Lessons from the deep study of rare tumours J Pathol 224 2011 306 308
8. S.H. Kresse, M. Skarn, H.O. Ohnstad, H.M. Namlos, B. Bjerkehagen, and O. Myklebost DNA copy number changes in high-grade malignant peripheral nerve sheath tumors by array CGH Mol Cancer 7 2008 48
9. K.K. Mantripragada, G. Spurlock, L. Kluwe, N. Chuzhanova, R.E. Ferner, and I.M. Frayling High-resolution DNA copy number profiling of malignant peripheral nerve sheath tumors using targeted microarray-based comparative genomic hybridization Clin Cancer Res 14 2008 1015 1024
10. G. Mechtersheimer, M. Otano-Joos, S. Ohl, A. Benner, T. Lehnert, and F. Willeke Analysis of chromosomal imbalances in sporadic and NF1-associated peripheral nerve sheath tumors by comparative genomic hybridization Genes Chromosomes Cancer 25 1999 362 369
11. J. Yang, A. Ylipaa, Y. Sun, H. Zheng, K. Chen, and M. Nykter Genomic and molecular characterization of malignant peripheral nerve sheath tumor identifies the IGF1R pathway as a primary target for treatment Clin Cancer Res 17 2011 7563 7573
12. H. Schmidt, P. Wurl, H. Taubert, A. Meye, M. Bache, and H.J. Holzhausen Genomic imbalances of 7p and 17q in malignant peripheral nerve sheath tumors are clinically relevant Genes Chromosomes Cancer 25 1999 205 211
13. T. Koga, H. Iwasaki, M. Ishiguro, A. Matsuzaki, and M. Kikuchi Frequent genomic imbalances in chromosomes 17, 19, and 22q in peripheral nerve sheath tumours detected by comparative genomic hybridization analysis J Pathol 197 2002 98 107
14. M. Ishiguro, H. Iwasaki, M. Takeshita, Y. Hirose, and Y. Kaneko A cytogenetic analysis in two cases of malignant peripheral nerve sheath tumor showing hypodiploid karyotype Oncol Rep 16 2006 225 232
15. H. Schmidt, H. Taubert, P. Wurl, M. Bache, F. Bartel, and H.J. Holzhausen Cytogenetic characterization of six malignant peripheral nerve sheath tumors: comparison of karyotyping and comparative genomic hybridization Cancer Genet Cytogenet 128 2001 14 23
16. S. Birindelli, F. Perrone, M. Oggionni, C. Lavarino, B. Pasini, and B. Vergani Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumors Lab Invest a J Tech Methods Pathol 81 2001 833 844
17. K.M. Reilly, K.W. Broman, R.T. Bronson, S. Tsang, D.A. Loisel, and E.S. Christy An imprinted locus epistatically influences Nstr1 and Nstr2 to control resistance to nerve sheath tumors in a neurofibromatosis type 1 mouse model Cancer Res 66 2006 62 68
18. R.A. Lothe, B. Smith-Sorensen, M. Hektoen, A.E. Stenwig, N. Mandahl, and G. Saeter Biallelic inactivation of TP53 rarely contributes to the development of malignant peripheral nerve sheath tumors Genes Chromosomes Cancer 30 2001 202 206
19. Y. Fang, A. Elahi, R.C. Denley, P.H. Rao, M.F. Brennan, and S.C. Jhanwar Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1 Anticancer Res 29 2009 1255 1262
20. Y. Nakagawa, A. Yoshida, K. Numoto, T. Kunisada, D. Wai, and N. Ohata Chromosomal imbalances in malignant peripheral nerve sheath tumor detected by metaphase and microarray comparative genomic hybridization Oncol Rep 15 2006 297 303
21. M. Endo, C. Kobayashi, N. Setsu, Y. Takahashi, K. Kohashi, and H. Yamamoto Prognostic significance of p14ARF, p15INK4b and p16INK4a inactivation in malignant peripheral nerve sheath tumors Clin Cancer Res 17 2011 3771 3782
22. L. Kohli, N. Kaza, N.J. Lavalley, K.L. Turner, S. Byer, and S.L. Carroll The pan erbB inhibitor PD168393 enhances lysosomal dysfunction-induced apoptotic death in malignant peripheral nerve sheath tumor cells Neuro-oncology 14 2012 266 277
23. S. Ammoun, C.H. Cunliffe, J.C. Allen, L. Chiriboga, F.G. Giancotti, and D. Zagzag ErbB/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma Neuro-oncology 12 2010 834 843
24. Y. Sekido Genomic abnormalities and signal transduction dysregulation in malignant mesothelioma cells Cancer Sci 101 2010 1 6
25. N. Holtkamp, E. Malzer, J. Zietsch, A.F. Okuducu, J. Mucha, and C. Mawrin EGFR and erbB2 in malignant peripheral nerve sheath tumors and implications for targeted therapy Neuro-oncology 10 2008 946 957
26. T. Koga, H. Iwasaki, M. Ishiguro, A. Matsuzaki, and M. Kikuchi Losses in chromosomes 17, 19, and 22q in neurofibromatosis type 1 and sporadic neurofibromas: a comparative genomic hybridization analysis Cancer Genet Cytogenet 136 2002 113 120
27. H. Schmidt, H. Taubert, A. Meye, P. Wurl, M. Bache, and F. Bartel Gains in chromosomes 7, 8q, 15q and 17q are characteristic changes in malignant but not in benign peripheral nerve sheath tumors from patients with Recklinghausen's disease Cancer Lett 155 2000 181 190
28. I. Szijan, D. Rochefort, C. Bruder, E. Surace, G. Machiavelli, and V. Dalamon NF2 tumor suppressor gene: a comprehensive and efficient detection of somatic mutations by denaturing HPLC and microarray-CGH Neuromolecular Med 3 2003 41 52
29. F. Parente, J. Grosgeorge, J.M. Coindre, P. Terrier, O. Vilain, and C. Turc-Carel Comparative genomic hybridization reveals novel chromosome deletions in 90 primary soft tissue tumors Cancer Genet Cytogenet 115 1999 89 95
30. J. Antinheimo, R. Sankila, O. Carpen, E. Pukkala, M. Sainio, and J. Jaaskelainen Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas Neurology 54 2000 71 76
31. J. Antinheimo, S.L. Sallinen, P. Sallinen, H. Haapasalo, H. Helin, and N. Horelli-Kuitunen Genetic aberrations in sporadic and neurofibromatosis 2 (NF2)-associated schwannomas studied by comparative genomic hybridization (CGH) Acta Neurochirurgica 142 2000 1099 1104 discussion 104-5
32. C. Warren, L.A. James, R.T. Ramsden, A. Wallace, M.E. Baser, and J.M. Varley Identification of recurrent regions of chromosome loss and gain in vestibular schwannomas using comparative genomic hybridisation J Med Genet 40 2003 802 806
33. T. Ikeda, S. Hashimoto, S. Fukushige, H. Ohmori, and A. Horii Comparative genomic hybridization and mutation analyses of sporadic schwannomas J Neurooncol 72 2005 225 230
34. T. Diaz de Stahl, C.M. Hansson, C. de Bustos, K.K. Mantripragada, A. Piotrowski, and M. Benetkiewicz High-resolution array-CGH profiling of germline and tumor-specific copy number alterations on chromosome 22 in patients affected with schwannomas Hum Genet 118 2005 35 44